820 related articles for article (PubMed ID: 24084650)
21. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
22. Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique.
Ito F; Fujimori H; Honnami H; Kawakami H; Kanamura K; Makino K
Colloids Surf B Biointerfaces; 2008 Oct; 66(1):65-70. PubMed ID: 18585903
[TBL] [Abstract][Full Text] [Related]
23. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
24. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
Aravind A; Jeyamohan P; Nair R; Veeranarayanan S; Nagaoka Y; Yoshida Y; Maekawa T; Kumar DS
Biotechnol Bioeng; 2012 Nov; 109(11):2920-31. PubMed ID: 22615073
[TBL] [Abstract][Full Text] [Related]
25. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
26. Investigation of the interaction of biodegradable micro- and nanoparticulate drug delivery systems with platelets.
Ramtoola Z; Lyons P; Keohane K; Kerrigan SW; Kirby BP; Kelly JG
J Pharm Pharmacol; 2011 Jan; 63(1):26-32. PubMed ID: 21155812
[TBL] [Abstract][Full Text] [Related]
27. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
28. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.
Lamprecht A; Ubrich N; Yamamoto H; Schäfer U; Takeuchi H; Maincent P; Kawashima Y; Lehr CM
J Pharmacol Exp Ther; 2001 Nov; 299(2):775-81. PubMed ID: 11602694
[TBL] [Abstract][Full Text] [Related]
29. Effect of microfluidization parameters on the physical properties of PEG-PLGA nanoparticles prepared using high pressure microfluidization.
Sani SN; Das NG; Das SK
J Microencapsul; 2009 Sep; 26(6):556-61. PubMed ID: 18946802
[TBL] [Abstract][Full Text] [Related]
30. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
Guo J; Gao X; Su L; Xia H; Gu G; Pang Z; Jiang X; Yao L; Chen J; Chen H
Biomaterials; 2011 Nov; 32(31):8010-20. PubMed ID: 21788069
[TBL] [Abstract][Full Text] [Related]
31. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
Chen YC; Hsieh WY; Lee WF; Zeng DT
J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
[TBL] [Abstract][Full Text] [Related]
32. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
Tahara K; Samura S; Tsuji K; Yamamoto H; Tsukada Y; Bando Y; Tsujimoto H; Morishita R; Kawashima Y
Biomaterials; 2011 Jan; 32(3):870-8. PubMed ID: 20934748
[TBL] [Abstract][Full Text] [Related]
33. Mucus-penetrating nanoparticles: Promising drug delivery systems for the photodynamic therapy of intestinal cancer.
Anderski J; Mahlert L; Mulac D; Langer K
Eur J Pharm Biopharm; 2018 Aug; 129():1-9. PubMed ID: 29778525
[TBL] [Abstract][Full Text] [Related]
34. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
[TBL] [Abstract][Full Text] [Related]
35. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of intra-articular delivery of hyaluronic acid functionalized biopolymeric nanoparticles in healthy rat knees.
Zille H; Paquet J; Henrionnet C; Scala-Bertola J; Leonard M; Six JL; Deschamp F; Netter P; Vergès J; Gillet P; Grossin L
Biomed Mater Eng; 2010; 20(3):235-42. PubMed ID: 20930333
[TBL] [Abstract][Full Text] [Related]
37. Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.
Zhou J; Guo D; Zhang Y; Wu W; Ran H; Wang Z
ACS Appl Mater Interfaces; 2014 Apr; 6(8):5566-76. PubMed ID: 24693875
[TBL] [Abstract][Full Text] [Related]
38. Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan.
Jiang T; Singh B; Li HS; Kim YK; Kang SK; Nah JW; Choi YJ; Cho CS
Biomaterials; 2014 Feb; 35(7):2365-73. PubMed ID: 24342722
[TBL] [Abstract][Full Text] [Related]
39. Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate.
Ishihara T; Kubota T; Choi T; Higaki M
J Pharmacol Exp Ther; 2009 May; 329(2):412-7. PubMed ID: 19244548
[TBL] [Abstract][Full Text] [Related]
40. Biodegradation and heart retention of polymeric microparticles in a rat model of myocardial ischemia.
Formiga FR; Garbayo E; Díaz-Herráez P; Abizanda G; Simón-Yarza T; Tamayo E; Prósper F; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):665-72. PubMed ID: 23523545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
